Vinorelbine Is an Effective and Safe Drug for AIDS-Related Kaposi’s Sarcoma: Results of a Phase II Study
- 7 April 2000
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (7) , 1550-1557
- https://doi.org/10.1200/jco.2000.18.7.1550
Abstract
PURPOSE: To assess the safety and efficacy of vinorelbine in patients with AIDS-related Kaposi’s sarcoma (KS). PATIENTS AND METHODS: From December 1994 to May 1997, within the Italian Cooperative G...Keywords
This publication has 20 references indexed in Scilit:
- A Risk and Benefit Assessment of Treatment for AIDS-Related Kaposi??s SarcomaDrug Safety, 1999
- Impact of Ilighly Effective Anti-retroviral Therapy on the Incidence of Malignancies Among HIV-infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.Journal of Clinical Oncology, 1998
- Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapyAIDS, 1997
- Insurance Type and Satisfaction with Medical Care Among HIV-Infected MenJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Treatment of HIV-associated Kaposi's sarcoma with paclitaxelThe Lancet, 1995
- Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trialThe American Journal of Medicine, 1991
- Treatment of Advanced Kaposiʼs Sarcoma Using a Combination of Bleomycin and VincristineAmerican Journal of Clinical Oncology, 1990
- Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?The Lancet, 1990
- Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.Journal of Clinical Oncology, 1984